About Us

Representative Introduction

Graduated from Yonsei University, Department of Business Administration
Dongyang Comprehensive Financial Securities Structured Finance (SF Team) Expert
Specializing in KRW and foreign currency bond issuance, asset securitization (ABS), NPL investment, and project finance.
Establishment and execution of IPO and M&A strategies
Building global investment partnerships and networks

Attracting corporate financial and strategic investment
Design of Structured Finance and Financing Solutions (ABS, PF, NPL, etc.)
Execution of corporate value enhancement and growth strategies such as IPOs and M&A
Development and planning of stem cell and exosome-based functional cosmetic ingredients, OEM manufacturing, and marketing
Establishment of domestic and international marketing and distribution strategies for healthcare products

Oxford University, UK (Pathology major)
Director of the Oxford Stem Cell Research Institute at Oxford University, UK
PhD / Visiting Professor, Medical School, Tianjin University, China
Served as Director of the National Institute of Life Sciences & Technology in Zhongshan, Guangdong Province, China
Director of the Korean Department at Beijing Road Hospital in Rizhao, Shandong Province
Director of Research at N-ClonTech Co. Ltd., Korea
Director and CEO of the New Generation Life Science Research Institute

Stem cells (umbilical cord/placenta-derived embryonic stem cells)
NK Cell, T-Cell Research and Development
Development of placenta-derived exosome (extracellular vesicle)-based therapeutics
Development of placenta-derived NK immune cells and stem cell therapies
Neurological diseases (Parkinson's, ALS, microscopic atrophy, stroke, dementia, etc.) Neural stem cell exosome therapy
IPSC (Induced Differentiated Stem Cells)
Umbilical Cord Wharton Jelly Research and Development (Excellent for Burns, Wounds, and Plastic Surgery): Freeze-dried